{
  "../data/ABEONA-THERAPEUTICS-INC/1996/10-Q/0000318306-96-000002/EX-10.18.txt": {
    "contract_id": "1995 Stock Option Plan (Unknown)",
    "title": "1995 Stock Option Plan (Unknown)",
    "contract_type": "License Agreement",
    "summary": "This is a stock option plan for Access Pharmaceuticals, Inc., as amended on 1996-03-28. It outlines the terms and conditions for granting stock options and stock appreciation rights to employees, consultants, and directors.",
    "execution_date": "1995-09-14",
    "effective_date": "1995-09-14",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "low sale prices of Common Stock on the stock exchange or market on which Common Stock is primarily traded on the date as of which such value is being determined or",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1996/10-Q/0000318306-96-000002/EX-10.18.txt",
      "year": "1996",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:13.235921",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1996/10-Q/0000318306-96-000003/EX-10.19.txt": {
    "contract_id": "LEASE AGREEMENT (Unknown)",
    "title": "LEASE AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Pollock Realty Corporation (licensor) and Access Pharmaceuticals, Inc. (licensee). Grant type: Nonexclusive. Upfront payment: $7,459.70. Territory: 1 region(s)",
    "execution_date": "None",
    "effective_date": "None",
    "upfront_payment": 7459.7,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Pollock Realty Corporation",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1996/10-Q/0000318306-96-000003/EX-10.19.txt",
      "year": "1996",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:18.090113",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1996/10-K/0000950146-96-000501/EX-10.16.txt": {
    "contract_id": "PATENT PURCHASE AGREEMENT (Unknown)",
    "title": "PATENT PURCHASE AGREEMENT (Unknown)",
    "contract_type": "Patent Purchase Agreement",
    "summary": "License agreement between David F. Ranney (licensor) and ACCESS PHARMACEUTICALS, INC (licensee). Grant type: Nonexclusive. Licenses 7 patent(s). Upfront payment: $7,500.00. Executed: 1994-04-05",
    "execution_date": "1994-04-05",
    "effective_date": "None",
    "upfront_payment": 7500.0,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "David F. Ranney",
    "licensee_name": "ACCESS PHARMACEUTICALS, INC",
    "patents_count": 7,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1996/10-K/0000950146-96-000501/EX-10.16.txt",
      "year": "1996",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:23.146352",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1996/10-K/0000950146-96-000501/EX-10.17.txt": {
    "contract_id": "FIRST AMENDMENT to PATENT PURCHASE AGREEMENT (Unknown)",
    "title": "FIRST AMENDMENT to PATENT PURCHASE AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between David F. Ranney (licensor) and ACCESS Pharmaceuticals, Inc. (licensee). Grant type: Nonexclusive. Upfront payment: $7,500.00. Executed: 1996-01-23",
    "execution_date": "1996-01-23",
    "effective_date": "None",
    "upfront_payment": 7500.0,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "David F. Ranney",
    "licensee_name": "ACCESS Pharmaceuticals, Inc.",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1996/10-K/0000950146-96-000501/EX-10.17.txt",
      "year": "1996",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:25.346942",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1997/10-Q/0000318306-97-000010/EX-10.12.txt": {
    "contract_id": "LICENSE AGREEMENT BETWEEN THE DOW CHEMICAL COMPANY AND THE COMPANY DATED JUNE 30, 1997 (Unknown)",
    "title": "LICENSE AGREEMENT BETWEEN THE DOW CHEMICAL COMPANY AND THE COMPANY DATED JUNE 30, 1997 (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between THE DOW CHEMICAL COMPANY (licensor) and Access Pharmaceuticals, Inc. (licensee). Grant type: Exclusive. Territory: 1 region(s). Executed: 1997-06-30",
    "execution_date": "1997-06-30",
    "effective_date": "1997-06-30",
    "upfront_payment": null,
    "exclusivity_grant_type": "Exclusive",
    "oem_type": null,
    "licensor_name": "THE DOW CHEMICAL COMPANY",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1997/10-Q/0000318306-97-000010/EX-10.12.txt",
      "year": "1997",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:31.654515",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1997/10-K/0000318306-97-000003/EX-10.19.txt": {
    "contract_id": "PLATINATE HPMA COPOLYMER ROYALTY AGREEMENT (Unknown)",
    "title": "PLATINATE HPMA COPOLYMER ROYALTY AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "This is a Platinate HPMA Copolymer Royalty Agreement between The London School of Pharmacy, University of London and Access Pharmaceuticals, Inc. dated November 19, 1996. It grants Access Pharmaceuticals exclusive rights to develop, manufacture, and sell products related to Cisplatin HPMA Copolymer technology worldwide, based on patents and know-how jointly owned by both parties. The agreement outlines terms for royalties, obligations, confidentiality, and termination.",
    "execution_date": "1996-11-19",
    "effective_date": "1996-11-19",
    "upfront_payment": null,
    "exclusivity_grant_type": "Exclusive",
    "oem_type": null,
    "licensor_name": "The School of Pharmacy, University of London",
    "licensee_name": "Access Pharmaceuticals, Inc",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1997/10-K/0000318306-97-000003/EX-10.19.txt",
      "year": "1997",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:43.040977",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q_A/0000318306-98-000012/EX-10.13.txt": {
    "contract_id": "AGREEMENT BETWEEN ACCESS PHARMACEUTICALS, INC. AND BLOCK DRUG COMPANY, INC. (Unknown)",
    "title": "AGREEMENT BETWEEN ACCESS PHARMACEUTICALS, INC. AND BLOCK DRUG COMPANY, INC. (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Block Drug Company, Inc. (licensor) and Access Pharmaceuticals, Inc. (licensee). Grant type: Nonexclusive. Licenses 1 patent(s). Licenses 1 product(s). Territory: 1 region(s). Executed: 1998-03-05",
    "execution_date": "1998-03-05",
    "effective_date": "1998-03-05",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Block Drug Company, Inc.",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 1,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q_A/0000318306-98-000012/EX-10.13.txt",
      "year": "1998",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:51.732760",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000007/EX-10.12.txt": {
    "contract_id": "LICENSE AGREEMENT BETWEEN STRAKAN LIMITED AND ACCESS PHARMACEUTICALS, INC. (Unknown)",
    "title": "LICENSE AGREEMENT BETWEEN STRAKAN LIMITED AND ACCESS PHARMACEUTICALS, INC. (Unknown)",
    "contract_type": "License Agreement",
    "summary": "This is a license agreement between Access Pharmaceuticals, Inc. and Strakan Ltd. for the development and commercial exploitation of a zinc compound patent for human use in dermatological and topical products. Strakan receives an exclusive global license.",
    "execution_date": "1998-02-26",
    "effective_date": "1998-02-26",
    "upfront_payment": null,
    "exclusivity_grant_type": "Exclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Strakan Ltd.",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000007/EX-10.12.txt",
      "year": "1998",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:16:57.481671",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000008/EX-10.13.txt": {
    "contract_id": "AGREEMENT BETWEEN ACCESS PHARMACEUTICALS, INC. AND BLOCK DRUG COMPANY, INC. (Unknown)",
    "title": "AGREEMENT BETWEEN ACCESS PHARMACEUTICALS, INC. AND BLOCK DRUG COMPANY, INC. (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Block Drug Company, Inc. (licensor) and Access Pharmaceuticals, Inc. (licensee). Licenses 1 patent(s). Licenses 1 product(s). Territory: 1 region(s). Executed: 1998-03-05",
    "execution_date": "1998-03-05",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "Block Drug Company, Inc.",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 1,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000008/EX-10.13.txt",
      "year": "1998",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:17:03.011904",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000008/EX-10.15.txt": {
    "contract_id": "REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "title": "REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "contract_type": "Registration Rights Agreement",
    "summary": "This is a Registration Rights Agreement between Access Pharmaceuticals, Inc. and the Investors listed on Schedule I, regarding the registration of the resale of shares under the Securities Act of 1933.",
    "execution_date": "None",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Investors",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000008/EX-10.15.txt",
      "year": "1998",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:17:06.884966",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000008/EX-10.14.txt": {
    "contract_id": "SALES AGENCY AGREEMENT (Unknown)",
    "title": "SALES AGENCY AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Sunrise Securities Corp. (licensee). Grant type: Exclusive. Licenses 1 product(s). Executed: 1998-06-18",
    "execution_date": "1998-06-18",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Exclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Sunrise Securities Corp.",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1998/10-Q/0000318306-98-000008/EX-10.14.txt",
      "year": "1998",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:17:11.172309",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1998/10-K/0000318306-98-000004/EX-10.11.txt": {
    "contract_id": "Agreement of Merger and Plan of Reorganization (Unknown)",
    "title": "Agreement of Merger and Plan of Reorganization (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Tacora Corporation (licensee). Grant type: Nonexclusive. Licenses 5 product(s). Upfront payment: $100,000.00. Territory: 2 region(s). Executed: 1997-05-23",
    "execution_date": "1997-05-23",
    "effective_date": "None",
    "upfront_payment": 100000.0,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Tacora Corporation",
    "patents_count": 0,
    "products_count": 5,
    "territories_count": 2,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1998/10-K/0000318306-98-000004/EX-10.11.txt",
      "year": "1998",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:17:15.099785",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1999/10-Q/0000318306-99-000014/EX-10.19.txt": {
    "contract_id": "REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "title": "REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Investors listed on Schedule I (licensee). Licenses 1 product(s)",
    "execution_date": "None",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Investors listed on Schedule I",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1999/10-Q/0000318306-99-000014/EX-10.19.txt",
      "year": "1999",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:17:18.284536",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1999/10-Q/0000318306-99-000014/EX-10.18.txt": {
    "contract_id": "SALES AGENCY AGREEMENT (Unknown)",
    "title": "SALES AGENCY AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Sunrise Securities Corp. (licensee). Grant type: Exclusive. Licenses 1 product(s). Territory: 1 region(s). Executed: 1999-07-20",
    "execution_date": "1999-07-20",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Exclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Sunrise Securities Corp.",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1999/10-Q/0000318306-99-000014/EX-10.18.txt",
      "year": "1999",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:17:27.324934",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/1999/10-K/0000318306-99-000004/EX-10.17.txt": {
    "contract_id": "LICENSE AGREEMENT BETWEEN BLOCK DRUG COMPANY AND ACCESS PHARMACEUTICALS, INC. (Unknown)",
    "title": "LICENSE AGREEMENT BETWEEN BLOCK DRUG COMPANY AND ACCESS PHARMACEUTICALS, INC. (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Block Drug Company, Inc. (licensor) and Access Pharmaceuticals, Inc. (licensee). Grant type: Exclusive. Licenses 1 patent(s). Licenses 1 product(s). Territory: 1 region(s). Executed: 1998-12-21",
    "execution_date": "1998-12-21",
    "effective_date": "1998-12-21",
    "upfront_payment": null,
    "exclusivity_grant_type": "Exclusive",
    "oem_type": null,
    "licensor_name": "Block Drug Company, Inc.",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 1,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/1999/10-K/0000318306-99-000004/EX-10.17.txt",
      "year": "1999",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:17:32.890372",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2000/10-Q/0000318306-00-000009/EX-10.23.txt": {
    "contract_id": "REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "title": "REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Investors (licensee). Grant type: Nonexclusive. Licenses 1 product(s). Territory: 1 region(s)",
    "execution_date": "None",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Investors",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2000/10-Q/0000318306-00-000009/EX-10.23.txt",
      "year": "2000",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:17:36.762249",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2000/10-Q/0000318306-00-000009/EX-10.22.txt": {
    "contract_id": "SALES AGENCY AGREEMENT (Unknown)",
    "title": "SALES AGENCY AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Sunrise Securities Corp. (licensee). Grant type: Exclusive. Licenses 1 product(s). Territory: 1 region(s). Executed: 2000-02-29",
    "execution_date": "2000-02-29",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Exclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Sunrise Securities Corp.",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2000/10-Q/0000318306-00-000009/EX-10.22.txt",
      "year": "2000",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:17:40.396377",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2000/10-K/0000318306-00-000003/EX-10.19.txt": {
    "contract_id": "EMPLOYMENT AGREEMENT OF DAVID P. NOWOTNIK, PH.D. (Unknown)",
    "title": "EMPLOYMENT AGREEMENT OF DAVID P. NOWOTNIK, PH.D. (Unknown)",
    "contract_type": "Employment Agreement",
    "summary": "License agreement between ACCESS Pharmaceuticals, Inc. (licensor) and David P. Nowotnik, Ph.D. (licensee). Executed: 1998-11-16",
    "execution_date": "1998-11-16",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "ACCESS Pharmaceuticals, Inc.",
    "licensee_name": "David P. Nowotnik, Ph.D.",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2000/10-K/0000318306-00-000003/EX-10.19.txt",
      "year": "2000",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:17:51.275034",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2000/10-K/0000318306-00-000003/EX-10.20.txt": {
    "contract_id": "401(K) PLAN (Unknown)",
    "title": "401(K) PLAN (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between The Guardian Insurance & Annuity Company, Inc. (licensor) and Access Pharmaceuticals, Inc. 401(K) Savings Plan (licensee). Grant type: Nonexclusive. Upfront payment: $850.00. Territory: 1 region(s)",
    "execution_date": "None",
    "effective_date": "1998-12-01",
    "upfront_payment": 850.0,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "The Guardian Insurance & Annuity Company, Inc.",
    "licensee_name": "Access Pharmaceuticals, Inc. 401(K) Savings Plan",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2000/10-K/0000318306-00-000003/EX-10.20.txt",
      "year": "2000",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:17:55.129624",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2001/10-Q/0000318306-01-500012/EX-10.19.txt": {
    "contract_id": "SUPPLEMENTAL LEASE AGREEMENT (Unknown)",
    "title": "SUPPLEMENTAL LEASE AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between POLLOCK REALTY CORPORATION (licensor) and Access Pharmaceuticals, Inc. (licensee). Grant type: Nonexclusive. Territory: 1 region(s). Executed: 2001-02-09",
    "execution_date": "2001-02-09",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "POLLOCK REALTY CORPORATION",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2001/10-Q/0000318306-01-500012/EX-10.19.txt",
      "year": "2001",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:18:01.703220",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2002/10-Q/0000318306-02-000010/EX-10.27.txt": {
    "contract_id": "ASSET SALE AGREEMENT (Unknown)",
    "title": "ASSET SALE AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Block Drug Company, Inc. (licensor) and Access Pharmaceuticals, Inc. (licensee). Licenses 1 product(s). Territory: 1 region(s). Executed: 2002-07-22",
    "execution_date": "2002-07-22",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "Block Drug Company, Inc.",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2002/10-Q/0000318306-02-000010/EX-10.27.txt",
      "year": "2002",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:18:06.455589",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2002/10-Q/0000318306-02-000005/EX-10.26.txt": {
    "contract_id": "ASSET SALE AGREEMENT (Unknown)",
    "title": "ASSET SALE AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between BIOA PTY LIMITED (licensor) and ACCESS PHARMACEUTICALS AUSTRALIA PTY LIMITED (licensee). Grant type: Nonexclusive. Upfront payment: $500,000.00. Executed: 2002-02-26",
    "execution_date": "2002-02-26",
    "effective_date": "None",
    "upfront_payment": 500000.0,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "BIOA PTY LIMITED",
    "licensee_name": "ACCESS PHARMACEUTICALS AUSTRALIA PTY LIMITED",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2002/10-Q/0000318306-02-000005/EX-10.26.txt",
      "year": "2002",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:18:10.468003",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2002/10-K/0000318306-02-000003/EX-10.25.txt": {
    "contract_id": "1995 Stock Option Plan Amendment (Unknown)",
    "title": "1995 Stock Option Plan Amendment (Unknown)",
    "contract_type": "License Agreement",
    "summary": "This document is an amendment to the 1995 Stock Option Plan of Access Pharmaceuticals, Inc. The amendment modifies Section 10.1 of the plan, detailing automatic grants of nonstatutory stock options to Non-Employee Directors.",
    "execution_date": "2001-05-21",
    "effective_date": "2001-05-21",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "ACCESS PHARMACEUTICALS, INC.",
    "licensee_name": "Unknown",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2002/10-K/0000318306-02-000003/EX-10.25.txt",
      "year": "2002",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:18:13.796703",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2002/10-K/0000318306-02-000003/EX-10.24.txt": {
    "contract_id": "Supplemental Lease Agreement (Unknown)",
    "title": "Supplemental Lease Agreement (Unknown)",
    "contract_type": "Lease Agreement",
    "summary": "This is a supplemental lease agreement to modify the original lease agreement between Pollock Realty Corporation and Access Pharmaceuticals, Inc.",
    "execution_date": "2001-09-20",
    "effective_date": "2001-09-15",
    "upfront_payment": 42000.0,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "POLLOCK REALTY CORPORATION",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2002/10-K/0000318306-02-000003/EX-10.24.txt",
      "year": "2002",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:18:20.144139",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2004/10-Q/0000318306-04-000016/EX-10.26.txt": {
    "contract_id": "LICENSE AND SUPPLY AGREEMENT (Unknown)",
    "title": "LICENSE AND SUPPLY AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between ACCESS PHARMACEUTICALS, INC. (licensor) and WYETH (licensee). Grant type: Exclusive. Licenses 1 product(s). Territory: 4 region(s). Executed: 2004-01-06",
    "execution_date": "2004-01-06",
    "effective_date": "2004-01-06",
    "upfront_payment": null,
    "exclusivity_grant_type": "Exclusive",
    "oem_type": null,
    "licensor_name": "ACCESS PHARMACEUTICALS, INC.",
    "licensee_name": "WYETH",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 4,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2004/10-Q/0000318306-04-000016/EX-10.26.txt",
      "year": "2004",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:18:25.206607",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2005/10-Q/0000318306-05-000009/EX-10.29.txt": {
    "contract_id": "SECURITIES PURCHASE AGREEMENT (Unknown)",
    "title": "SECURITIES PURCHASE AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "This is a Securities Purchase Agreement dated 2005-03-30 between Access Pharmaceuticals, Inc. and the Buyers listed on Schedule I. The agreement outlines the terms and conditions for the purchase and sale of secured convertible debentures.",
    "execution_date": "2005-03-30",
    "effective_date": "None",
    "upfront_payment": 2633000.0,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "ACCESS PHARMACEUTICALS, INC.",
    "licensee_name": "Buyers listed on Schedule I",
    "patents_count": 0,
    "products_count": 2,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2005/10-Q/0000318306-05-000009/EX-10.29.txt",
      "year": "2005",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:18:32.170746",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2005/10-Q/0000318306-05-000009/EX-10.28.txt": {
    "contract_id": "Secured Debenture (Unknown)",
    "title": "Secured Debenture (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Highgate House Funds, Ltd. (licensee). Executed: 2006-03-30",
    "execution_date": "2006-03-30",
    "effective_date": "2005-03-30",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Highgate House Funds, Ltd.",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2005/10-Q/0000318306-05-000009/EX-10.28.txt",
      "year": "2005",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:18:37.535759",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2005/10-Q/0000318306-05-000009/EX-10.27.txt": {
    "contract_id": "STANDBY EQUITY DISTRIBUTION AGREEMENT (Unknown)",
    "title": "STANDBY EQUITY DISTRIBUTION AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between ACCESS PHARMACEUTICALS, INC. (licensor) and CORNELL CAPITAL PARTNERS, LP (licensee). Grant type: Nonexclusive. Licenses 1 product(s). Territory: 1 region(s). Executed: 2005-03-30",
    "execution_date": "2005-03-30",
    "effective_date": "None",
    "upfront_payment": 0.0,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "ACCESS PHARMACEUTICALS, INC.",
    "licensee_name": "CORNELL CAPITAL PARTNERS, LP",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2005/10-Q/0000318306-05-000009/EX-10.27.txt",
      "year": "2005",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:18:41.913753",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2005/10-Q/0000318306-05-000009/EX-10.30.txt": {
    "contract_id": "INVESTOR REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "title": "INVESTOR REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between ACCESS PHARMACEUTICALS, INC. (licensor) and Investors listed on Schedule I (licensee). Executed: 2005-03-30",
    "execution_date": "2005-03-30",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "ACCESS PHARMACEUTICALS, INC.",
    "licensee_name": "Investors listed on Schedule I",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2005/10-Q/0000318306-05-000009/EX-10.30.txt",
      "year": "2005",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:18:45.423059",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.29.txt": {
    "contract_id": "SECURED DEBENTURE ACCESS PHARMACEUTICALS, INC. (Unknown)",
    "title": "SECURED DEBENTURE ACCESS PHARMACEUTICALS, INC. (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Highgate House Funds, Ltd. (licensee). Grant type: Nonexclusive. Executed: 2006-03-30",
    "execution_date": "2006-03-30",
    "effective_date": "2005-03-30",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Highgate House Funds, Ltd.",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.29.txt",
      "year": "2006",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:18:50.107823",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.28.txt": {
    "contract_id": "SECURITIES PURCHASE AGREEMENT (Unknown)",
    "title": "SECURITIES PURCHASE AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between ACCESS PHARMACEUTICALS, INC. (licensor) and Buyers (licensee). Executed: 2005-03-30",
    "execution_date": "2005-03-30",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "ACCESS PHARMACEUTICALS, INC.",
    "licensee_name": "Buyers",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.28.txt",
      "year": "2006",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:18:54.391063",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.32.txt": {
    "contract_id": "PLEDGE AND ESCROW AGREEMENT (Unknown)",
    "title": "PLEDGE AND ESCROW AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between ACCESS PHARMACEUTICALS, INC. (licensor) and CORNELL CAPITAL PARTNERS, LP; HIGHGATE HOUSE FUNDS, LTD. (licensee). Grant type: Nonexclusive. Licenses 1 product(s). Executed: 2005-03-30",
    "execution_date": "2005-03-30",
    "effective_date": "2005-03-30",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "ACCESS PHARMACEUTICALS, INC.",
    "licensee_name": "CORNELL CAPITAL PARTNERS, LP; HIGHGATE HOUSE FUNDS, LTD.",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.32.txt",
      "year": "2006",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:18:58.269916",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.33.txt": {
    "contract_id": "ESCROW AGREEMENT (Unknown)",
    "title": "ESCROW AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between ACCESS PHARMACEUTICALS, INC. (licensor) and Investor(s) (licensee). Grant type: Nonexclusive. Licenses 1 product(s). Upfront payment: $2,633,000.00. Executed: 2005-03-30",
    "execution_date": "2005-03-30",
    "effective_date": "None",
    "upfront_payment": 2633000.0,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "ACCESS PHARMACEUTICALS, INC.",
    "licensee_name": "Investor(s)",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.33.txt",
      "year": "2006",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:01.654778",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.27.txt": {
    "contract_id": "STANDBY EQUITY DISTRIBUTION AGREEMENT (Unknown)",
    "title": "STANDBY EQUITY DISTRIBUTION AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between ACCESS PHARMACEUTICALS, INC. (licensor) and CORNELL CAPITAL PARTNERS, LP (licensee). Grant type: Nonexclusive. Licenses 1 product(s). Territory: 1 region(s). Executed: 2005-03-30",
    "execution_date": "2005-03-30",
    "effective_date": "None",
    "upfront_payment": 0.0,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "ACCESS PHARMACEUTICALS, INC.",
    "licensee_name": "CORNELL CAPITAL PARTNERS, LP",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.27.txt",
      "year": "2006",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:05.107011",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.31.txt": {
    "contract_id": "SECURITY AGREEMENT (Unknown)",
    "title": "SECURITY AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between ACCESS PHARMACEUTICALS, INC. (licensor) and BUYER(S) listed on Schedule I attached to the Securities Purchase Agreement dated the date hereof (licensee). Grant type: Nonexclusive. Licenses 2 product(s). Executed: 2005-03-30",
    "execution_date": "2005-03-30",
    "effective_date": "2005-03-30",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "ACCESS PHARMACEUTICALS, INC.",
    "licensee_name": "BUYER(S) listed on Schedule I attached to the Securities Purchase Agreement dated the date hereof",
    "patents_count": 0,
    "products_count": 2,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.31.txt",
      "year": "2006",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:08.886764",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.30.txt": {
    "contract_id": "INVESTOR REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "title": "INVESTOR REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between ACCESS PHARMACEUTICALS, INC. (licensor) and Investors listed on Schedule I (licensee). Grant type: Nonexclusive. Licenses 1 product(s). Upfront payment: $2,633,000.00. Territory: 1 region(s). Executed: 2005-03-30",
    "execution_date": "2005-03-30",
    "effective_date": "None",
    "upfront_payment": 2633000.0,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "ACCESS PHARMACEUTICALS, INC.",
    "licensee_name": "Investors listed on Schedule I",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.30.txt",
      "year": "2006",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:18.188894",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.34.txt": {
    "contract_id": "REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "title": "REGISTRATION RIGHTS AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between ACCESS PHARMACEUTICALS, INC. (licensor) and CORNELL CAPITAL PARTNERS, LP (licensee). Grant type: Nonexclusive. Licenses 1 product(s). Executed: 2005-03-30",
    "execution_date": "2005-03-30",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "ACCESS PHARMACEUTICALS, INC.",
    "licensee_name": "CORNELL CAPITAL PARTNERS, LP",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2006/10-Q_A/0000318306-06-000001/EX-10.34.txt",
      "year": "2006",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:20.384160",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2007/10-Q/0000318306-07-000060/10.43.html": {
    "contract_id": "AMENDMENT TO ORACLE &AMP; AFFILIATES CONVERTIBLE NOTES (Unknown)",
    "title": "AMENDMENT TO ORACLE &AMP; AFFILIATES CONVERTIBLE NOTES (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Oracle Partners LP; Oracle Institutional Partners LP; SAM Oracle Investments Inc.; Oracle Offshore Ltd. (licensee). Licenses 1 product(s). Executed: 2007-10-26",
    "execution_date": "2007-10-26",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Oracle Partners LP; Oracle Institutional Partners LP; SAM Oracle Investments Inc.; Oracle Offshore Ltd.",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2007/10-Q/0000318306-07-000060/10.43.html",
      "year": "2007",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:23.085710",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2007/10-Q/0000318306-07-000060/10.44.html": {
    "contract_id": "AMENDMENT TO AMENDED AND RESTATED 7.5% SECURED CONVERTIBLE PROMISSORY NOTE DUE OCTOBER 25, 2007 (Unknown)",
    "title": "AMENDMENT TO AMENDED AND RESTATED 7.5% SECURED CONVERTIBLE PROMISSORY NOTE DUE OCTOBER 25, 2007 (Unknown)",
    "contract_type": "License Agreement",
    "summary": "This is an amendment to a promissory note, changing the due date from October 25, 2007 to November 15, 2007.",
    "execution_date": "2007-10-25",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "SCO Capital Partners LLC",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2007/10-Q/0000318306-07-000060/10.44.html",
      "year": "2007",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:25.871278",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2008/S-1/0001140361-08-006400/10.27.html": {
    "contract_id": "AMENDED AND RESTATED PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (Unknown)",
    "title": "AMENDED AND RESTATED PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Purchasers (licensee). Grant type: Nonexclusive. Licenses 2 product(s). Executed: 2008-02-04",
    "execution_date": "2008-02-04",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Purchasers",
    "patents_count": 0,
    "products_count": 2,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2008/S-1/0001140361-08-006400/10.27.html",
      "year": "2008",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:30.192686",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2008/S-1/0001140361-08-006400/10.23.html": {
    "contract_id": "PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (Unknown)",
    "title": "PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Purchasers named herein on Schedule 1 (licensee). Grant type: Nonexclusive. Licenses 2 product(s). Territory: 1 region(s). Executed: 2007-11-07",
    "execution_date": "2007-11-07",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Purchasers named herein on Schedule 1",
    "patents_count": 0,
    "products_count": 2,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2008/S-1/0001140361-08-006400/10.23.html",
      "year": "2008",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:34.474843",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2008/S-1/0001140361-08-006400/10.24.html": {
    "contract_id": "Investor Rights Agreement (Unknown)",
    "title": "Investor Rights Agreement (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Purchasers (licensee). Grant type: Nonexclusive. Executed: 2007-11-10",
    "execution_date": "2007-11-10",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Purchasers",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2008/S-1/0001140361-08-006400/10.24.html",
      "year": "2008",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:38.420135",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2008/S-1/0001140361-08-006400/10.28.html": {
    "contract_id": "Amended and Restated Investor Rights Agreement (Unknown)",
    "title": "Amended and Restated Investor Rights Agreement (Unknown)",
    "contract_type": "Investor Rights Agreement",
    "summary": "This is an Amended and Restated Investor Rights Agreement made as of 2008-02-04, between Access Pharmaceuticals, Inc. and the Purchasers listed on Schedule 1. It amends and restates the Original Investor Rights Agreement dated 2007-11-10, in connection with the amendment and restatement of the Original Purchase Agreement dated 2007-11-07.",
    "execution_date": "2008-02-04",
    "effective_date": "None",
    "upfront_payment": 0.0,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Purchasers",
    "patents_count": 0,
    "products_count": 3,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2008/S-1/0001140361-08-006400/10.28.html",
      "year": "2008",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:43.009133",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2008/10-Q/0000318306-08-000027/10.30.html": {
    "contract_id": "AMENDMENT TO EMPLOYMENT AGREEMENT (Unknown)",
    "title": "AMENDMENT TO EMPLOYMENT AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Jeffrey B. Davis (licensee). Grant type: Nonexclusive. Executed: 2008-04-09",
    "execution_date": "2008-04-09",
    "effective_date": "2008-04-09",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Jeffrey B. Davis",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2008/10-Q/0000318306-08-000027/10.30.html",
      "year": "2008",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:45.530257",
    "mtime": 1750965720.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2010/S-1_A/0000318306-10-000002/10.29.html": {
    "contract_id": "Securities Purchase Agreement (Unknown)",
    "title": "Securities Purchase Agreement (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Purchaser (licensee). Grant type: Nonexclusive. Licenses 1 product(s). Territory: 1 region(s). Executed: 2010-01-01",
    "execution_date": "2010-01-01",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Purchaser",
    "patents_count": 0,
    "products_count": 1,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2010/S-1_A/0000318306-10-000002/10.29.html",
      "year": "2010",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:48.932383",
    "mtime": 1750965780.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2010/S-1_A/0000318306-10-000007/10.29.html": {
    "contract_id": "Securities Purchase Agreement (Unknown)",
    "title": "Securities Purchase Agreement (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Purchaser (licensee). Grant type: Nonexclusive. Executed: 2010-01-01",
    "execution_date": "2010-01-01",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Purchaser",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2010/S-1_A/0000318306-10-000007/10.29.html",
      "year": "2010",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:52.080830",
    "mtime": 1750965780.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2010/10-K/0000318306-10-000018/10.9.html": {
    "contract_id": "AMENDMENT TO RIGHTS AGREEMENT (Unknown)",
    "title": "AMENDMENT TO RIGHTS AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and American Stock Transfer & Trust Company (licensee). Executed: 2007-11-09",
    "execution_date": "2007-11-09",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "American Stock Transfer & Trust Company",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2010/10-K/0000318306-10-000018/10.9.html",
      "year": "2010",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:54.783569",
    "mtime": 1750965780.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2010/8-K/0000318306-10-000080/10.1.html": {
    "contract_id": "SECURITIES PURCHASE AGREEMENT (Unknown)",
    "title": "SECURITIES PURCHASE AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Purchaser (licensee). Grant type: Nonexclusive. Licenses 2 product(s). Territory: 1 region(s). Executed: 2010-12-09",
    "execution_date": "2010-12-09",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": "Nonexclusive",
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Purchaser",
    "patents_count": 0,
    "products_count": 2,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2010/8-K/0000318306-10-000080/10.1.html",
      "year": "2010",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:19:59.241687",
    "mtime": 1750965780.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2011/8-K/0000318306-11-000023/10.1.html": {
    "contract_id": "SECURITIES PURCHASE AGREEMENT (Unknown)",
    "title": "SECURITIES PURCHASE AGREEMENT (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Access Pharmaceuticals, Inc. (licensor) and Investors (licensee). Executed: 2011-11-01",
    "execution_date": "2011-11-01",
    "effective_date": "None",
    "upfront_payment": null,
    "exclusivity_grant_type": null,
    "oem_type": null,
    "licensor_name": "Access Pharmaceuticals, Inc.",
    "licensee_name": "Investors",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 0,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2011/8-K/0000318306-11-000023/10.1.html",
      "year": "2011",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:20:03.626482",
    "mtime": 1750965780.0
  },
  "../data/ABEONA-THERAPEUTICS-INC/2014/8-K/0000318306-14-000027/10.30.html": {
    "contract_id": "LICENSE AGREEMENT - PLASMA TECHNOLOGIES LLC (Unknown)",
    "title": "LICENSE AGREEMENT - PLASMA TECHNOLOGIES LLC (Unknown)",
    "contract_type": "License Agreement",
    "summary": "License agreement between Plasma Technologies, LLC (licensor) and Access Pharmaceuticals, Inc. (licensee). Grant type: Exclusive. Upfront payment: $5,000,000.00. Territory: 1 region(s)",
    "execution_date": "None",
    "effective_date": "2014-09-19",
    "upfront_payment": 5000000.0,
    "exclusivity_grant_type": "Exclusive",
    "oem_type": null,
    "licensor_name": "Plasma Technologies, LLC",
    "licensee_name": "Access Pharmaceuticals, Inc.",
    "patents_count": 0,
    "products_count": 0,
    "territories_count": 1,
    "metadata": {
      "file_path": "../data/ABEONA-THERAPEUTICS-INC/2014/8-K/0000318306-14-000027/10.30.html",
      "year": "2014",
      "filing_type": "Unknown",
      "accession": "Unknown",
      "exhibit": "Unknown"
    },
    "processed_at": "2025-07-10T10:20:16.398699",
    "mtime": 1750965780.0
  }
}